Finn R.
- Country
- Denmark
- Department
- Lungeambulatorium
Research Overview
- Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients
- A Phase 2b, Multicenter, Randomized, Double-blind, Parallel group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis
- A Multicentre, Parallel-group, Phase IIb, Randomised, Double blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO).
Data & Insights
Has run more than one trial at 55 of 331 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in the treatment and management of Chronic Obstructive Pulmonary Disease (COPD), with particular focus on advanced therapeutic interventions using combination inhalation treatments.
- Pulmonary Function Optimization
- Bronchodilator Therapy
- Respiratory Disease Management
Their research interests encompass innovative approaches in respiratory medicine, particularly in the area of cardiopulmonary outcomes in COPD patients.
Therapeutic Innovation
The investigator focuses on evaluating complex therapeutic combinations, including triple therapy approaches for respiratory conditions, with emphasis on metered-dose inhaler applications.
- Combination Therapy Development
- Inhaler Technology
- Treatment Optimization
Their work involves assessment of various therapeutic combinations including budesonide, glycopyrronium, and formoterol fumarate in respiratory care.
Clinical Outcomes
The investigator's research centers on measuring and improving severe cardiopulmonary outcomes in chronic respiratory conditions, with particular attention to comparative therapeutic efficacy.
- Treatment Effectiveness Analysis
- Clinical Response Assessment
- Patient Outcome Improvement
Their expertise extends to evaluating the impact of various treatment modalities on respiratory disease progression and management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.